Hematuria differential diagnosis: Difference between revisions
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) No edit summary |
||
Line 56: | Line 56: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| colspan="2" style="background: #F5F5F5; padding: 5px;" | - | | colspan="2" style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Electron microscopy shows mesangial hypercellularity and increased mesangial matrix | |||
| colspan="2" style="background: #F5F5F5; padding: 5px;" | | | colspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
* Focal or diffuse mesangial proliferation | |||
* Extracellular matrix expansion | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | * IgA deposited in a diffuse granular pattern in the mesangium | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | - | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Alport syndrome|Hereditary nephritis (Alport syndrome)]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Alport syndrome|Hereditary nephritis (Alport syndrome)]] | ||
Line 81: | Line 85: | ||
* Red cell [[casts]] | * Red cell [[casts]] | ||
* Cylindrical [[casts]] | * Cylindrical [[casts]] | ||
| style="background: #F5F5F5; padding: 5px;" | | |||
* Shrunken kidneys | |||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* High-frequency sensorineural hearing loss | |||
| colspan="2" style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Monoclonal antibodies directed against alpha-3 (IV), alpha-4 (IV), and alpha-5 (IV) chains of type IV collagen | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Genetic Analysis | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Poststreptococcal glomerulonephritis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Poststreptococcal glomerulonephritis]] | ||
| style="background: #F5F5F5; padding: 5px;" | +/- | |||
| style="background: #F5F5F5; padding: 5px;" | + | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |+ | |||
| style="background: #F5F5F5; padding: 5px;" |+ | |||
| style="background: #F5F5F5; padding: 5px;" |+ | |||
| style="background: #F5F5F5; padding: 5px;" |+ | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Edema | |||
* Anemia | |||
* Increased Blood Pressure | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Urine samples for protein and blood | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Renal Biopsy | |||
* Irregularly thin and attenuated GBM | |||
* Splitting of GBM | |||
* Scarring | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Hypercellularity of the glomeruli | |||
* Endothelial and mesangial cells and migrant inflammatory cells | |||
* Hyaline droplets | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Immunoglobulin G and C3 in a diffuse granular pattern | |||
* Starry sky pattern | |||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[MPGN|Mesangioproliferative glomerulonephritis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[MPGN|Mesangioproliferative glomerulonephritis]] | ||
Line 135: | Line 154: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Focal segmental glomerulosclerosis|Focal segmental glomerular sclerosis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Focal segmental glomerulosclerosis|Focal segmental glomerular sclerosis]] | ||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |+ | |||
| style="background: #F5F5F5; padding: 5px;" |+ | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Nephrotic syndrome | |||
* ESRD | |||
* Pleural effusion | |||
* Ascites | |||
* Abdominal pain | |||
** | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Urinalysis reveals large amounts of protein, along with hyaline and broad waxy casts | |||
* Hepatitis B or C infection | |||
* Antineutrophil cytoplasmic antibody titers, serum protein electrophoresis | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Shrunken kidneys | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Segmental solidification in the perihilar region and peripheral areas, specially the tubular pole | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Coarsely granular deposits of IgM and C3 | |||
| style="background: #F5F5F5; padding: 5px;" |Biopsy | |||
| style="background: #F5F5F5; padding: 5px;" | - | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Rapidly progressive glomerulonephritis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Rapidly progressive glomerulonephritis]] | ||
| style="background: #F5F5F5; padding: 5px;" |+ | |||
| style="background: #F5F5F5; padding: 5px;" |+ | |||
| style="background: #F5F5F5; padding: 5px;" |+ | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |+ | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Abdominal pain | |||
* Painful cutaneous nodules | |||
* Migratory polyarthropathy | |||
* Sinusitis | |||
* Cough | |||
* Hemoptysis. | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Low iron | |||
* Eosinophilia | |||
* Increased serum creatinine level | |||
* Eleated LDH and CPK | |||
* Proteinuria | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |Diffuse, proliferative, necrotizing glomerulonephritis with crescent formation | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Biospy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |80% of patients have ANCA-positive microscopic polyangiitis | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lupus nephritis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lupus nephritis]] | ||
Line 527: | Line 569: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Polyarteritis nodosa]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Polyarteritis nodosa]] | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |-/+ | | style="background: #F5F5F5; padding: 5px;" | -/+ | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |- | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Fatigue (physical)|Fatigue]] | * [[Fatigue (physical)|Fatigue]] | ||
Line 855: | Line 897: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Prostatitis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Prostatitis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |- | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |+ | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |- | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |+ | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |+ | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |+ | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |- | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |- | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,024: | Line 1,066: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| rowspan=" | | rowspan="14" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Dark urine]] | ||
| rowspan=" | | rowspan="6" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemoglobinuria]] | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Autoimmune hemolytic anemia]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Autoimmune hemolytic anemia]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,152: | Line 1,194: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| rowspan="8" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Myoglobinuria]] | |||
| rowspan=" | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Crush injury]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Crush injury]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 1,322: | Line 1,343: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Haff disease]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Haff disease]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 19:52, 20 July 2018
Hematuria Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hematuria differential diagnosis On the Web |
American Roentgen Ray Society Images of Hematuria differential diagnosis |
Risk calculators and risk factors for Hematuria differential diagnosis |
Steven C. Campbell, M.D., Ph.D. Associate Editor(s)-in-Chief: Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [1]
Overview
Gross hematuria(GH) must be distinguished from pigmenturia, which may be due to endogenous sources (e.g., bilirubin, myoglobin,and porphyrins), foods ingested (e.g., beets and rhubarb), drugs (e.g., phenazopyridine), and simple dehydration. This distinction can be made easily by urinalysis with microscopy. Notably, myoglobinuria and other factors can cause false-positive chemical tests for hemoglobin, so urine microscopy is required to confirm the diagnosis of hematuria. GH also must be distinguished from vaginal bleeding in women, which usually can be achieved by obtaining a careful menstrual history, collecting the specimen when the patient is not having menstrual or gynecologic bleeding, or, if necessary, obtaining a catheterized specimen. GH may also be detected by the presence of blood spotting on the undergarments of incontinent patients. After ruling out vaginal bleeding and mimics of hematuria, a urologic source must be suspected.
Differential Diagnosis
Hematuria should be differentiated from other disease which mimic hematuria especially hemoglobinuria and myoglobinuria which are dipstick positive but negative for microscopy.
Hematuria differential diagnosis
Differentiating the diseases that can cause hematuria:
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||||||||
Lab Findings | Imaging | Histopathology | |||||||||||||||||||
Low back pain | Fever | Nausea/Vomiting | Urinary symptoms | Hypertension | Pitting edema | Other | Ultrasonography | CT scan | Other | ||||||||||||
Dysuria | Frequency | Oliguria | Light microscopy | Immunoflourescence pattern | |||||||||||||||||
Hematuria | Glomerular diseases | IgA nephropathy (Berger nephropathy) | + | - | - | - | + | + | + | - | - | - | - |
|
|
|
Biopsy | - | |||
Hereditary nephritis (Alport syndrome) | - | - | - | - | - | - | + | - |
|
|
- |
|
- |
|
|
- | |||||
Poststreptococcal glomerulonephritis | +/- | + | - | - | + | + | + | + |
|
|
Renal Biopsy
|
- | - |
|
|
Biopsy | - | ||||
Mesangioproliferative glomerulonephritis | |||||||||||||||||||||
Focal segmental glomerular sclerosis | - | - | - | - | - | - | + | + |
|
|
|
- | - |
|
|
Biopsy | - | ||||
Rapidly progressive glomerulonephritis | + | + | + | - | - | - | + | - |
|
|
- | - | - | Diffuse, proliferative, necrotizing glomerulonephritis with crescent formation | - | Biospy | 80% of patients have ANCA-positive microscopic polyangiitis | ||||
Lupus nephritis | |||||||||||||||||||||
Thin basement membrane disease | |||||||||||||||||||||
Fabry disease | |||||||||||||||||||||
Tubulointerstitial diseases | Renal papillary necrosis | ||||||||||||||||||||
Acute interstitial nephritis | + | + | + | ||||||||||||||||||
Analgesic | |||||||||||||||||||||
Nephrolithiasis | |||||||||||||||||||||
Reflux nephropathy (hydronephrosis) | |||||||||||||||||||||
Malignancy | Renal cell carcinoma (RCC) | ||||||||||||||||||||
Nephroblastoma | |||||||||||||||||||||
Transitional cell carcinoma (TCC) | |||||||||||||||||||||
Prostate cancer | |||||||||||||||||||||
Familial diseases | Polycystic kidney disease | + | - | - | - | - | - | + | + |
|
|
|
Genetic testing demonstrates: |
|
|
Ultrasound | |||||
Vascular diseases | Renal vein thrombosis | + | + | + | - | - | - | - | - |
|
|
|
|
||||||||
Malignant hypertension | |||||||||||||||||||||
Polyarteritis nodosa | - | -/+ | - | - | - | + | + | - |
|
||||||||||||
Wegner's granulomatosis polyangiitis | |||||||||||||||||||||
Henoch-Schönlein purpura | |||||||||||||||||||||
Lower urinary tract diseases | Benign prostatic hyperplasia | ||||||||||||||||||||
Urolithiasis | |||||||||||||||||||||
Interstitial cystitis | |||||||||||||||||||||
Radiogenic cystitis | |||||||||||||||||||||
Systemic diseases | Coagulopathy (hemophilia) | ||||||||||||||||||||
Sickle cell anemia | |||||||||||||||||||||
Abdominal aortic aneurysm | |||||||||||||||||||||
Lymphomas | |||||||||||||||||||||
Multiple myeloma | |||||||||||||||||||||
Infectious diseases | Pyelonephritis | + | + | + | + | + | + | - | - |
|
|
Contrast nephrograms
|
|
- | |||||||
Cystitis | - | - | - | + | + | + | - | - |
|
|
|
MRI
|
|||||||||
Prostatitis | - | + | - | + | + | + | - | - | |||||||||||||
Urethritis | |||||||||||||||||||||
Epididymitis | |||||||||||||||||||||
Cytomegalovirus | |||||||||||||||||||||
Infectious mononucleosis | |||||||||||||||||||||
Condylomata acuminata | |||||||||||||||||||||
Urogenital trauma | Inserted bladder or ureteral catheters | ||||||||||||||||||||
Drugs | Anticoagulants | ||||||||||||||||||||
Dark urine | Hemoglobinuria | Autoimmune hemolytic anemia | |||||||||||||||||||
Microangiopathic hemolytic anemia | |||||||||||||||||||||
Thrombotic thrombocytopenic purpura | |||||||||||||||||||||
Paroxysmal nocturnal hemoglobinuria | |||||||||||||||||||||
Paroxysmal cold hemoglobinuria | |||||||||||||||||||||
Falciparum malaria | |||||||||||||||||||||
Myoglobinuria | Crush injury | ||||||||||||||||||||
Vigorous muscle exercise | |||||||||||||||||||||
Hyperthermia (Heat stroke) | |||||||||||||||||||||
Electric shock | |||||||||||||||||||||
Prolonged seizure | |||||||||||||||||||||
Polymyositis | |||||||||||||||||||||
Trichinosis | |||||||||||||||||||||
Haff disease |